PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Treating left atrial appendage could dampen long standing persistent AF

2015-08-30
(Press-News.org) LONDON, UK - In patients with long-standing persistent atrial fibrillation (AF) despite standard treatment, additional electrical isolation of an area called the left atrial appendage (LAA) can improve freedom from AF without increasing complications, results of the BELIEF study show. The findings were presented today in a Hot Line session at ESC Congress 2015. "Empirical left atrial appendage isolation, along with the standard approach of pulmonary vein isolation (PVI) and ablation of extra-pulmonary triggers is superior to the standard approach alone in enhancing the long-term success rate of catheter ablation," reported investigator Luigi Di Biase, MD, PhD from Montefiore-Albert Einstein Center for Heart & Vascular Care, New York, USA and Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, Texas, USA. "We first proposed in 2010 that the left atrial appendage was a relevant, under-reported trigger for AF, and now this trial confirms our findings," he added. The study included 173 patents with "long-standing persistent" AF - defined as extending beyond one year. Patients were randomly assigned to undergo standard treatment alone (PVI and ablation of extra-pulmonary triggers, n=88), or standard treatment plus the addition of LAA ablation (n=85). For the primary endpoint of recurrence of AF at one year, 28% of standard treatment patients were recurrence-free compared to 56% of patients who had the additional LAA ablation (hazard ratio [HR] 1.92; p=0.001). For patients who were not recurrence-free in either group, LAA isolation was performed in a second procedure. At 24 months, after an average of 1.3 procedures, the cumulative success rate was 76% in the LAA ablation group and 56% in the standard treatment group. (HR 2.24; p= 0.003). There was no difference in complication rates between groups at follow up, including transient ischemic attacks or strokes, however the mean radiofrequency time was longer in the LAA group (93 versus 77 minutes; P END


ELSE PRESS RELEASES FROM THIS DATE:

Patient education does not impact apixaban adherence

2015-08-30
LONDON, UK - Adherence to the oral anticoagulant apixaban among patients with atrial fibrillation (AF) was no better for those who received an educational program compared to those who did not, results of the international, randomised AEGEAN trial show. The results, presented today at ESC Congress 2015, were nevertheless "quite encouraging," according to lead investigator Gilles Montalescot, MD, PhD, from the Institut de Cardiologie, Centre Hospitalier Universitaire Pitié-Salpêtri?re, in Paris, France. "We used the best possible tools for the educational program, ...

Adenosine triphosphate does not improve efficacy of pulmonary vein isolation

2015-08-30
LONDON, UK - Late recurrence of atrial fibrillation (AF) is not reduced in patients whose pulmonary vein isolation (PVI) treatment incorporates the addition of adenosine triphosphate (ATP), according to results of the UNDER-ATP trial. Results of the trial, presented at ESC Congress 2015, add to the ongoing debate about ATP use in this setting. The major cause of AF recurrence after PVI has been reported to be electrical reconnection between the left atrium and pulmonary veins, which re-establishes abnormal rhythm, said study investigator Atsushi Kobori, MD, from Kobe ...

Leadless pacemaker study assesses safety and efficacy

2015-08-30
LONDON, UK - A leadless cardiac pacemaker showed "good safety and reliable function" during the initial six months of follow-up in the LEADLESS II study, investigators reported during a Hot Line presentation at the ESC congress 2015. The findings, published simultaneously in the New England Journal of Medicine, suggest the device is effective and safe, and can serve as an alternative to conventional transvenous pacemakers in patients with indications for permanent pacing, said principal investigator Vivek Reddy, MD. "Leadless cardiac pacemakers have the potential to ...

Antiarrhythmia drugs no impact on late AF recurrence

2015-08-30
LONDON, UK - In patients with atrial fibrillation (AF) treated with radiofrequency catheter ablation, the addition of antiarrhythmic drugs (AADs) for 90 days after the procedure did not reduce arrhythmia recurrence rates at one year, according to results of the Efficacy of Antiarrhythmic Drugs Short-Term Use after Catheter Ablation for Atrial Fibrillation (EAST-AF) trial. Results of the study, presented as a Hot Line at ESC Congress 2015 The study did show a temporary benefit of AAD, but the effect disappeared as soon as medication was stopped, suggesting no benefit to ...

Multiple risk factors cancel impact of atrial fibrillation on ischemic stroke risk

2015-08-30
London, UK - 30 Aug 2015: The impact of atrial fibrillation on ischaemic stroke risk in elderly patients is eliminated with multiple risk factors, according to an 11 year study in more than 425 000 patients presented at ESC Congress today.1 The findings suggest that stroke prevention in the elderly may need to focus on the concomitant effects of multiple risk factors rather than on a specific risk factor such as atrial fibrillation (AF). "The incidence of ischaemic stroke increases with greater numbers of cardiovascular risk factors," said principal investigator Dr Yutao ...

Rapid, more sensitive test speeds up chest pain triage

2015-08-30
LONDON, England - 30 August, 2015: Patients arriving at the emergency department with chest pain suggestive of acute myocardial infarction (AMI) can be triaged more quickly and more safely using a new rapid assay with refined cut-offs, German research suggests. The Biomarkers in Acute Cardiovascular Care (BACC) study, presented as a Hot Line at ESC Congress 2015, suggests this new algorithm can reduce mortality and cut triage times to one hour, compared to the standard three-hour approach. "There is an urgent need for fast decision-making for this growing patient population," ...

Antimineralocorticoids offer no benefit in heart attack patients without heart failure

2015-08-30
LONDON, UK - 30 August, 2015: Heart attack patients without heart failure derive no benefit from the addition of mineralocortoid receptor antagonists (MRA), to standard therapy, results of the ALBATROSS study show. The Hot Line findings, reported at ESC Congress 2015, "do not warrant the extension of MRA use" to such patients, said the study's principal investigator Gilles Montalescot, MD, PhD. MRAs, also known as aldosterone antagonists, inhibit sodium retention and excretion of potassium and magnesium, and therefore "there is an indication for MRA therapy in MI ...

Peri-infarct pacing does not improve outcomes in patients with large myocardial infarction

2015-08-30
LONDON, UK - In patients with a large myocardical infarction (MI), pacing, with the left ventricular (LV) lead placed in the area of the lesion (peri-infarct) did not prevent further enlargement of the heart (remodeling), nor did it improve functional or clinical outcomes after 18 months, according to results of the Pacing Remodeling Prevention Therapy trial (PRomPT) trial. In MI patients with large infarcts, medical therapy and rapid restoration of blood flow to the area is not always enough to prevent cardiac remodeling. One reason for remodeling may be the response ...

Cyclosporine does not improve outcomes after PCI

2015-08-30
LONDON, UK - 30 August, 2015: The immunosuppressant drug cyclosporine did not improve clinical outcomes compared to placebo in patients receiving percutaneous coronary intervention (PCI) for the more severe form of heart attack known as ST-segment elevation myocardial infarction (STEMI). Results of the CIRCUS trial, presented today in a Hot Line session at ESC Congress 2015, and published simultaneously in the New England Journal of Medicine. showed that the drug, administered prior to PCI, had no impact on a composite of all-cause death, hospitalisation for - or worsening ...

Surprise cardiac finding predicts future risk

2015-08-30
LONDON, UK - In patients with chronic ischemic heart disease, a small left ventricle with thick walls, is the strongest predictor of morphologic remodelling, which is generally considered a first step towards heart failure, according to unexpected findings presented today at ESC Congress 2015. Results of the DOPPLER-CIP (which stands for "Determining Optimal non-invasive Parameters for the Prediction of Left vEntricular morphologic and functional Remodeling in Chronic Ischemic Patients") study were not expected and, if confirmed by other studies, "could completely change ...

LAST 30 PRESS RELEASES:

Researchers use ultrasound holograms to influence brain networks

Unique videos show how trawling restrictions brings back life to the sea

Whooping cough can be fatal in young infants, experts warn

Knee-d for excellence: New regional training hub keeps surgeons sharp for ageing population

The Lancet: Billions lack access to healthy diets as food systems drive climate and health crises, but sustainable, equitable solutions are within reach, says new EAT-Lancet report

Countries with highest reported levels of hearing loss have lowest use of hearing aids

Early medical abortion at home up to 12 weeks is safe, effective, and comparable to hospital care

New approach to gravitational wave detection opens the Milli-Hz Frontier

Rice membrane extracts lithium from brines with greater speed, less waste

Exercise lowers disease risk. This researcher wants to understand how

Hurricane evacuation patterns differ based on where the storm hits

Stem Cell Reports welcomes new members to its Editorial Board

Researchers develop molecular qubits that communicate at telecom frequencies

Mayo Clinic awarded up to $40 million by ARPA-H for pioneering air safety research

People with Down syndrome have early neuroinflammation

CNIO researchers create the “human repairome”, a catalogue of DNA “scars” that will help define personalized cancer treatments

Strengthening biosecurity screening for genes that encode proteins of concern

Global wildfire disasters are growing in frequency and cost

Wildfire management: Reactive response and recovery, or proactive mitigation and prevention

Phosphine detected in the atmosphere of a low-temperature brown dwarf

Scientists develop rapid and scalable platform for in planta directed evolution

New tiny prehistoric fish species unlocks origins of catfish and carp

Plant microbiota: War and peace under the surface

Fossilized ear bones rewrite the history of freshwater fish

Detection of phosphine in a brown dwarf atmosphere raises more questions

USF study: Ancient plankton hint at steadier future for ocean life

MIT researchers find a simple formula could guide the design of faster-charging, longer-lasting batteries

Towards efficient room-temperature fluorine recovery from fluoropolymers

Mapping RNA-protein 'chats' could uncover new treatments for cancer and brain disease

The hidden burden of solitude: How social withdrawal influences the adolescent brain

[Press-News.org] Treating left atrial appendage could dampen long standing persistent AF